ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CLA1314 |
|
1310460-86-6 |
Modotuximab (Anti-ERBB1 / EGFR / HER1) 95+% |
— | |
CLA1304 |
|
959963-46-3 |
Imgatuzumab (Anti-ERBB1 / EGFR / HER1) 95+% |
— | |
CLA1303 |
|
1310460-85-5 |
Futuximab 95+% |
— | |
CLA1300 |
|
1314238-96-4 |
Duligotuzumab 95+% |
— | |
CLA1295 |
|
1262787-83-6 |
Patritumab (Anti-ERBB3 / HER3) 95+% |
— | |
CLA1240 |
|
725735-28-4 |
Intetumumab 95+% |
— | |
CLA1221 |
|
906805-06-9 |
Necitumumab (anti-EGFR) 95+% |
— | |
CLA1163 |
|
667901-13-5 |
Anti-Human EGFR Monoclonal Antibody(Zalutumumab) 95+% |
— | |
CLA1072 |
|
828933-51-3 |
Nimotuzumab 95+% |
— | |
CL1632 |
|
850140-72-6 |
Afatinib (BIBW2992)
|
C24H25ClFN5O3 | |
CL1651 |
|
388082-78-8 |
Lapatinib Ditosylate Monohydrate 98+% |
C29H26ClFN4O4S | |
CLA1026 |
|
339177-26-3 |
Panitumumab 98+% |
— | |
CL2211 |
|
1421373-65-0 |
AZD-9291 (Osimertinib; Mereletinib) 98+% |
C28H33N7O2 | |
HL1010 |
|
989-51-5 |
(-)-Epigallocatechin Gallate; EGCG 98+% |
C22H18O11 | |